2.72
price down icon3.64%   -0.03
 
loading
전일 마감가:
$2.75
열려 있는:
$2.8
하루 거래량:
8,075
Relative Volume:
0.22
시가총액:
$46.21M
수익:
$709.00K
순이익/손실:
$-43.14M
주가수익비율:
-0.2648
EPS:
-10.27
순현금흐름:
$-20.35M
1주 성능:
-5.36%
1개월 성능:
-15.06%
6개월 성능:
-6.03%
1년 성능:
-33.58%
1일 변동 폭
Value
$2.56
$2.80
1주일 범위
Value
$2.50
$2.80
52주 변동 폭
Value
$2.285
$4.305

OncoCyte Corporation Stock (OCX) Company Profile

Name
명칭
OncoCyte Corporation
Name
전화
510-775-0515
Name
주소
1010 Atlantic Avenue, Suite 102, Alameda, CA
Name
직원
16
Name
트위터
@OncocyteCorp
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
OCX's Discussions on Twitter

OCX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
OCX 2.6704 46.21M 709.00K -43.14M -20.35M -10.27
VRTX 449.72 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.06 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.00 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.52 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.14 24.89B 3.30B -501.07M 1.03B 11.54

OncoCyte Corporation Stock (OCX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-05-24 다운그레이드 Stephens Overweight → Equal-Weight
2022-03-14 다운그레이드 KeyBanc Capital Markets Overweight → Sector Weight
2022-01-07 개시 Stephens Overweight
2022-01-06 재개 Piper Sandler Overweight
2021-03-17 재개 Needham Buy
2021-01-07 업그레이드 The Benchmark Company Speculative Buy → Buy
2020-12-16 업그레이드 Piper Sandler Neutral → Overweight
2020-11-30 개시 BTIG Research Buy
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-07-30 재확인 The Benchmark Company Speculative Buy
2020-07-01 다운그레이드 Piper Sandler Overweight → Neutral
2020-06-30 다운그레이드 Chardan Capital Markets Buy → Neutral
2020-06-02 개시 Needham Buy
2019-02-13 개시 Piper Jaffray Overweight
2019-01-29 업그레이드 Janney Neutral → Buy
2018-12-19 재개 Lake Street Buy
모두보기

OncoCyte Corporation 주식(OCX)의 최신 뉴스

pulisher
Nov 15, 2024

Seasoned Financial executive joins Oncocyte as CFO - Reuters.com

Nov 15, 2024
pulisher
Nov 14, 2024

PURA VIDA INVESTMENTS, LLC Expands Stake in OncoCyte Corp - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

OncoCyte stock maintains Buy rating with Needham after GraftAssure RUO launch - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

OncoCyte Corporation (NASDAQ:OCX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

OncoCyte: Q3 Earnings Snapshot - Darien Times

Nov 13, 2024
pulisher
Nov 13, 2024

OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress i - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

OncoCyte Corp Reports Q3 2024 Earnings and Strategic Updates - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

OncoCyte Corp (OCX) Q3 2024 Earnings: EPS of -$0.98 Misses Estimates, Revenue Falls Short at $115,000 - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025 - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Oncocyte Corporation (OCX) Quarterly 10-Q Report - Quartz

Nov 12, 2024
pulisher
Nov 11, 2024

What to Expect from OncoCyte's Earnings - Benzinga

Nov 11, 2024
pulisher
Nov 06, 2024

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 - ForexTV.com

Nov 06, 2024
pulisher
Nov 02, 2024

OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 02, 2024
pulisher
Oct 27, 2024

StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) - MarketBeat

Oct 27, 2024
pulisher
Oct 17, 2024

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - The Manila Times

Oct 17, 2024
pulisher
Oct 16, 2024

Oncocyte Corp expands equity incentive plan - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

Oncocyte Corp expands equity incentive plan By Investing.com - Investing.com Australia

Oct 16, 2024
pulisher
Oct 16, 2024

OncoCyte shares maintain Buy rating from Needham By Investing.com - Investing.com Nigeria

Oct 16, 2024
pulisher
Oct 15, 2024

OncoCyte shares maintain Buy rating from Needham - Investing.com

Oct 15, 2024
pulisher
Oct 09, 2024

OncoCyte Corp (OCX) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst Financial Challenges - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Oncocyte reports breakthrough in breast cancer diagnostics - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial - The Manila Times

Oct 08, 2024
pulisher
Oct 08, 2024

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial - StockTitan

Oct 08, 2024
pulisher
Oct 05, 2024

Broadwood Partners L.P. buys Oncocyte shares for $3.88 million By Investing.com - Investing.com Australia

Oct 05, 2024
pulisher
Oct 04, 2024

Oncocyte CFO acquires $99,999 worth of company shares By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

Oncocyte CFO acquires $99,999 worth of company shares - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Broadwood Partners L.P. buys Oncocyte shares for $3.88 million - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

OncoCyte Secures Funding Through Private Share Sale - Yahoo Finance

Oct 04, 2024
pulisher
Oct 03, 2024

OncoCyte Corporation announced that it expects to receive $10.203435 million in funding from Bio-Rad Laboratories, Inc. - Marketscreener.com

Oct 03, 2024
pulisher
Oct 03, 2024

LENSAR reports inducement grants - Medical Buyer

Oct 03, 2024
pulisher
Oct 03, 2024

Oncocyte Corporation enters into securities purchase agreement - Medical Buyer

Oct 03, 2024
pulisher
Oct 03, 2024

Oncocyte Signs Leading Transplant Centers in US and Germany - The Manila Times

Oct 03, 2024
pulisher
Oct 02, 2024

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules - ForexTV.com

Oct 02, 2024
pulisher
Oct 02, 2024

Sandfire Resources America Inc. Announces Incentive Plan Grants - The Manila Times

Oct 02, 2024

OncoCyte Corporation (OCX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):